A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy

Journal of Radiation Research

Volumn 51, Issue 5, 2010, Pages 621-626

  Kumar, Sanath ^a,b   Freytag, Svend O ^a   Barton, Kenneth N ^a   Burmeister, Jay ^b   Joiner, Michael C ^b   Sedghi, Bijan ^c   Movsas, Benjamin ^a   Binns, Peter J ^d   Kim, Jae Ho ^a   Brown, Stephen L ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c University Laboratories   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMIC EMISSION SPECTROSCOPY; INDUCTIVELY COUPLED PLASMA; IODINE COMPOUNDS; RATS; SODIUM IODIDE; VIRUSES;

BORON CONCENTRATIONS; BORON NEUTRON CAPTURE THERAPY; BORON NEUTRONCAPTURE THERAPY; CANCER CELLS; NORMAL TISSUE; NOVEL METHODS; NOVEL STRATEGIES; ORTHOTOPIC; SYMPORTERS; TISSUE CELLS;

TUMORS;

ADENOVIRIDAE; MUS; MUS MUSCULUS; RATTUS;

EID: 77958597717     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.10036     Document Type: Article

References (33)

1. Locher GL (1936) Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol 36: 1-13.
2. Soloway AH, et al (1997) The rationale and requirements for the development of boron neutron capture therapy of brain tumors. J Neurooncol 33: 9-18.
3. Barth RF, et al (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11: 3987-4002.
4. Barth RF, et al (1992) Boron neutron capture therapy for cancer. Realities and prospects. Cancer 70: 2995-3007.
5. Barth RF, et al (1999) Boron neutron capture therapy of brain tumors: an emerging therapeutic modality. Neurosurgery 44: 433-450.
6. Binns PJ, Riley KJ and Harling OK (2005) Epithermal neutron beams for clinical studies of boron neutron capture therapy: a dosimetric comparison of seven beams. Radiat Res 164: 212-220.
7. Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am 271: 58-65.
8. Yamamoto T, Nakai K and Matsumura A (2008) Boron neutron capture therapy for glioblastoma. Cancer Letters 262: 143-152.
9. Kawabata S, et al (2009) Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res 50: 51-60.
10. Miyatake S, et al (2007) Boron neutron capture therapy for malignant tumors related to meningiomas. Neurosurgery 61: 82-90.
11. Kato I, et al (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61: 1069-1073.
12. Ariyoshi Y, et al (2007) Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Oncol Rep 18: 861-866.
13. Soloway AH, Hatanaka H and Davis MA (1967) Penetration of brain and brain tumor. VII. Tumor-binding Sulfhydryl Boron Compounds. J Med Chem 10: 714-717.
14. Coderre JA, et al (2003) Boron neutron capture therapy, cellular targeting of high linear energy transfer radiation. Technol Cancer Res Treat 2: 355-375.
15. Wittig A, Sauerwein WA and Coderre JA (2000) Mechanisms of transport of p-borono phenylalanine through the cell membrane in vitro. Radiat Res 153: 173-180.
16. Miyatake SI, Kawabata S and Kajimoto Y. (2006) Clinical results of BNCT for malignant gliomas using BSH and BPA simultaneously. In: Proceedings 12th International Congress on Neutron Capture Therapy: 31-34.
17. Henriksson R, et al (2008) Boron neutron capture therapy (BNCT) for glioblastoma multiforme, a phase II study evalu-ating a prolonged high-dose of boronophenylalanine (BPA). Radiother Oncol 88: 183-191.
18. Barth RF, et al (2004) Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 58: 267-277.
19. Carrasco N (1993) Iodide transport in the thyroid gland. Biochim Biophys Acta 1154: 65-82.
20. Eskandari S, et al (1997) Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 272: 27230- 27238.
21. Barton KN, et al (2003) GENIS: gene expression of sodium iodide symporter for non-invasive imaging of gene therapy vectors and quantification of gene expression in vivo. Mol Ther 8: 508-518.
22. Anbar M, Guttmann S and Lewitus Z (1960) The accumulation of fluoroborate ions in thyroid glands of rats. Endocrinology 66: 888-890.
23. Anbar M and Inbar M (1964) Studies on the accumulation of fluoroborate ions in the thyroid of mice. Acta Endocrinol 46: 639-642.
24. Fairchild RG and Bond VP (1980) Current status of boron-10-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. Int J Radiat Oncol Biol Phys 11: 831-840.
25. Hawthorne MF and Lee MW (2003) A critical assessment of boron target compounds for boron neutron capture therapy. J Neurooncol 62: 33-45.
26. Ganly I, Mautner V and Balmain A. (2000) Productive repli-cation of human adenoviruses in mouse epidermal cells. J Virol 74: 2895-2899.
27. Ternovoi VV, et al (2005) Productive replication of human adenovirus type 5 in canine cells. J Virol 79: 1308-1311.
28. Kawabata S, et al (2009) Survival benefit from boron neutron capture therapy for Newly Diagnosed Glioblastoma. Appl Radiat Isot 67: 15-18.
29. Pellettieri L, et al (2008) An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme. Acta Neurol Scand 117: 191-197.
30. Freytag SO, et al (2007) Five-year follow-up of trial of replication competent adenovirus mediated suicide gene therapy for treatment of prostate cancer. Mol Ther 15: 636-642.
31. Tazebay UH, et al (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6: 871-878.
32. Wapnir IL, et al (2004) The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res 10: 4294- 4302.
33. Willhauck MJ, et al (2008) Functional sodium iodide sym-porter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat 109: 263-272.